Caris Life Sciences, Inc. Common Stock CAI
$29.98
-3.04%
at last close
Financials (TTM)
- Revenue
- $989.61 million
- Net Income
- $105.14 million
- Net Margin
- 10.62%
- Return on Equity
- 17.77%
- Debt-to-Equity
- 0.66
- P/E Ratio
- 17.74
- Price / Book
- 14.77
- Price / Sales
- 8.83
Over the trailing twelve months, Caris Life Sciences, Inc. Common Stock generated revenue of $989.61 million and net income of $105.14 million, a net margin of 10.62%.
At the last closing price of $29.98, CAI trades at 17.74 times trailing earnings and 8.83 times sales, with a market capitalization of $8.74 billion.
Key Stats
- Last Close
- $29.98
- Market Cap
- $8.74 billion
- 52-Week Range
- $14.19 – $42.50
- Average Volume
- 5.52 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.